Type2diabetes clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for

  • Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

    open to eligible people ages 22-70

    This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes (T2D) inadequately controlled on non-insulin glucose-lowering medications.

    at UCLA

  • Type 2 Diabetes and Blood Brain Barrier Improvement

    open to eligible people ages 40-65

    The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.

    at UCLA

Our lead scientists for Type2diabetes research studies include .

Last updated: